These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 9756796)

  • 1. Description of two new isolates of Streptococcus pneumoniae in spain that are highly resistant to cefotaxime.
    Ruiz J; Sempere M; Simarro E; Fenoll A
    Antimicrob Agents Chemother; 1998 Oct; 42(10):2768-9. PubMed ID: 9756796
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of penicillin/amoxicillin non-susceptibility on the activity of third-generation cephalosporins against Streptococcus pneumoniae.
    Fenoll A; Giménez MJ; Robledo O; Aguilar L; Tarragó D; Granizo JJ; Martín-Herrero JE
    Eur J Clin Microbiol Infect Dis; 2008 Jan; 27(1):75-80. PubMed ID: 17943330
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antimicrobial susceptibilities and serotypes of Streptococcus pneumoniae in southwestern Japan and correlation of penicillin-binding protein 2b and 2x mutations in susceptibilities of penicillin G and cefotaxime.
    Nagai K; Matsuo Y; Tsumura N; Sakata Y; Kato H
    Diagn Microbiol Infect Dis; 2000 Jun; 37(2):107-13. PubMed ID: 10863105
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro activity of cefditoren and other antimicrobial agents against 288 Streptococcus pneumoniae and 220 Haemophilus influenzae clinical strains isolated in Zaragoza, Spain.
    Seral C; Suárez L; Rubio-Calvo C; Gómez-Lus R; Gimeno M; Coronel P; Durán E; Becerril R; Oca M; Castillo FJ
    Diagn Microbiol Infect Dis; 2008 Oct; 62(2):210-5. PubMed ID: 18715733
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro activity of cefepime and cefotaxime compared to six other agents against 350 penicillin-susceptible and penicillin-resistant Streptococcus pneumoniae.
    Gomez-Lus R; Navarro C; Egido P; Aspiroz C; Goñi P; Vergara Y; Garcia C; Duran E; Castillo J; Rubio MC
    J Chemother; 2000 Feb; 12(1):17-21. PubMed ID: 10768511
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Emergence of extremely high penicillin and cefotaxime resistance and high-level levofloxacin resistance in clinical isolates of Streptococcus pneumoniae in Hungary.
    Glatz K; Szabó D; Szabó G; Boriszova D; Rozgonyi F
    J Antimicrob Chemother; 2001 Nov; 48(5):731-4. PubMed ID: 11679565
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro activities of cefotaxime, ceftriaxone, ceftazidime, cefpirome, and penicillin against Streptococcus pneumoniae isolates.
    Barry AL; Brown SD; Novick WJ
    Antimicrob Agents Chemother; 1995 Oct; 39(10):2193-6. PubMed ID: 8619565
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro activity of cefpirome against Streptococcus pneumoniae strains with decreased susceptibility to cefotaxime.
    Fremaux A; Sissia G; Spicq C; Geslin P
    Diagn Microbiol Infect Dis; 1998 Jul; 31(3):501-2. PubMed ID: 9635247
    [No Abstract]   [Full Text] [Related]  

  • 9. Non-Penicillin-Binding protein mediated high-level penicillin and cephalosporin resistance in a Hungarian clone of Streptococcus pneumoniae.
    Smith AM; Klugman KP
    Microb Drug Resist; 2000; 6(2):105-10. PubMed ID: 10990264
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Emergence of a high-level cefotaxime-resistant Streptococcus pneumoniae strain in New Zealand.
    Brett MS
    J Med Microbiol; 2001 Feb; 50(2):173-176. PubMed ID: 11211225
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activity of penicillin and three third-generation cephalosporins against US isolates of Streptococcus pneumoniae: a 1995 surveillance study.
    Thornsberry C; Burton PH; Vanderhoof BH
    Diagn Microbiol Infect Dis; 1996 Jun; 25(2):89-95. PubMed ID: 8882895
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro killing of penicillin-susceptible, -intermediate, and -resistant strains of Streptococcus pneumoniae by cefotaxime, ceftriaxone, and ceftizoxime: a comparison of bactericidal and inhibitory activity with achievable CSF levels.
    Stratton CW; Aldridge KE; Gelfand MS
    Diagn Microbiol Infect Dis; 1995; 22(1-2):35-42. PubMed ID: 7587048
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Antibiotic resistance in 622 Streptococcus pneumoniae isolated from blood and cerebrospinal fluid in 33 Spanish hospitals participating in the European Antimicrobial Resistance Surveillance System (2000)].
    Oteo J; Cruchaga S; Campos J; Sáez-Nieto JA; Baquero F;
    Enferm Infecc Microbiol Clin; 2003 Jan; 21(1):12-9. PubMed ID: 12550039
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro activities of broad-spectrum cephalosporins against nonmeningeal isolates of Streptococcus pneumoniae: MIC interpretation using NCCLS M100-S12 recommendations.
    Sahm DF; Thornsberry C; Mayfield DC; Jones ME; Karlowsky JA
    J Clin Microbiol; 2002 Feb; 40(2):669-74. PubMed ID: 11825993
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Short-term bactericidal activity of amoxicillin and cefotaxime against penicillin-susceptible and -resistant pneumococcal strains: an in vitro pharmacodynamic simulation.
    Fenoll A; Casal J; Giménez MJ; Jado I; Aguilar L
    J Chemother; 2000 Apr; 12(2):124-8. PubMed ID: 10789550
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bactericidal activity of cefotaxime, desacetylcefotaxime, rifampin, and various combinations tested at cerebrospinal fluid levels against penicillin-resistant Streptococcus pneumoniae.
    Cormican MG; Erwin ME; Jones RN
    Diagn Microbiol Infect Dis; 1995; 22(1-2):119-23. PubMed ID: 7587024
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro activity of telithromycin against Streptococcus pneumoniae resistant to other antibiotics, including cefotaxime.
    Fuchs PC; Barry AL; Brown SD
    J Antimicrob Chemother; 2002 Feb; 49(2):399-401. PubMed ID: 11815588
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antimicrobial resistance of 1,113 Streptococcus pneumoniae isolates from patients with respiratory tract infections in Spain: results of a 1-year (1996-1997) multicenter surveillance study. The Spanish Surveillance Group for Respiratory Pathogens.
    Baquero F; García-Rodríguez JA; García de Lomas J; Aguilar L
    Antimicrob Agents Chemother; 1999 Feb; 43(2):357-9. PubMed ID: 9925532
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro susceptibility of Streptococcus pneumoniae strains to nine beta-lactam antibiotics and the killing kinetics of cephalosporins alone and in combination with vancomycin or gentamicin.
    Marton A; Major P
    Microb Drug Resist; 1996; 2(3):361-9. PubMed ID: 9158796
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Emergence of penicillin-resistant Streptococcus pneumoniae ocular infections.
    Penland RL; Wilhelmus KR
    Cornea; 1998 Mar; 17(2):135-40. PubMed ID: 9520187
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.